Spyre Therapeutics Inc

NEW
STU:3920 (USA)  
€ 79.5 +1.5 (+1.92%) Sep 16
At Loss
P/B:
8.57
Market Cap:
€ 6.97B ($ 8.00B)
Enterprise V:
€ 6.11B ($ 7.01B)
Volume:
0
Avg Vol (2M):
40.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (STU:3920) Operating Data Charts